Repros Therapeutics Inc. Announces Proposed Public Offering of Common Stock

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas, June 17, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (Nasdaq:RPRX) today announced that it has commenced an underwritten public offering of up to 3,000,000 shares of its common stock. All of the shares in the offering are to be sold by Repros Therapeutics Inc.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC